Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

SHE:300878 Revenue

Zhejiang Wecome Pharmaceutical Company had revenue of 56.50M CNY in the quarter ending June 30, 2026, with 26.13% growth. This brings the company's revenue in the last twelve months to 236.86M, up 40.34% year-over-year. In the year 2025, Zhejiang Wecome Pharmaceutical Company had annual revenue of 225.27M, down -35.86%.

• Revenue (ttm): 236.86M
• Revenue Growth: +40.34%
• P/S Ratio: 19.54
• Revenue / Employee: 442.73K
• Employees: 535
• Market Cap: 4.63B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	225.27M	-125.93M	-35.86%
Dec 31, 2024	351.20M	-168.42M	-32.41%
Dec 31, 2023	519.62M	-12.82M	-2.41%
Jan 1, 2023	532.44M	-100.51M	-15.88%
Jan 1, 2022	632.95M	10.19M	1.64%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error